Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Biogen Pharmachem Industries has submitted a compliance certificate under SEBI Regulation 74(5) for the quarter ended 31st March 2025. The certificate was issued by their Registrar and Share Transfer Agent, Satellite Corporate Services Private Limited. It confirms that no physical share certificates were received for dematerialization during the quarter. The filing is a routine regulatory compliance requirement and has been shared with BSE, NSDL, and CDSL.
This is a routine compliance filing with no material impact on the business, operations, or stock price. It simply confirms there were no physical share certificates submitted for demat conversion during the quarter.